CD4 and hepatitis B virus infection: In mice, the administration of anti-CD25 mAbs to deplete Tregs enhanced CD4 and CD8 T cell responses to BCG and hepatitis B vaccines (23), and preexisting CD4+CD25+ Tregs suppressed BCG responses in vitro and in vivo (24).